This EuroPCR 2025 session focuses on the management of refractory heart failure by integrating oral medical therapy with advanced device-based interventions.
A transdisciplinary panel, including an anesthesiologist, a cardiac surgeon, and interventional cardiologists, uses a case-based discussion to highlight the value of coordinated care in patients unresponsive to standard treatments.
Through the case of a 69-year-old man with repeated heart failure, severe left ventricular dysfunction, and mitral regurgitation, the speakers examine therapeutic options such as Cardiac Resynchronization Therapy (CRT) and Mitral TEER. The session underscores the importance of real-time, transdisciplinary decision-making to optimize both patient outcomes and quality of life.
This case report and/or content does not reflect the opinion of iHF or iheartfunction.com, nor does it engage their responsibility.
Advancing trans-disciplinary innovation in heart failure drugs and device solutions to improve patient care
